3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Motor Activity
2
Leukemia, Myeloid, Acute
2
Postoperative Cognitive Complications
1
Neoplasms
1
Malnutrition
1
Liver Diseases
1
Gastrointestinal Neoplasms
1
Frailty
1
Emergence Delirium
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Breast Cancer Female
1
Interventions
Cisplatin
15
Gemcitabine
14
durvalumab
9
pembrolizumab
7
Oxaliplatin
6
Bevacizumab
6
Capecitabine
5
lenvatinib
4
S 1 (combination)
3
Liquid Biopsy
3
Irinotecan
3
Folfox protocol
3
Fluorouracil
3
Carboplatin
3
zanidatamab
2
tremelimumab
2
envafolimab
2
Trastuzumab
2
Nivolumab
2
Leucovorin
2
Injections
2
Blood Specimen Collection
2
Albumin-Bound Paclitaxel
2
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
poly ICLC
1
niraparib
1
neratinib
1
larotrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Control Groups
×
90 days
×
Clear all
No trials found.